METHODS:
For experimental assessment, endogenous melanoma mice (Braf;Pten;Tyr CreER ) were locally induced with activated tamoxifen and monitored for spontaneous tumor growth. When tumors reached 1cm in diameter, several wound-in-tumor experimental conditions were pursued in individual mice: Wound biopsy (with stenting of the wound edges to prevent rapid contraction), incisional wound (primary closure) or control (uninjured tumor tissue). On post-operative day (POD) 14, mice were sacrificed and tissue was stained with picosirius red to characterize the connective tissue. Stented dermal wounds in C57B/6J mice were used for comparison and uninjured skin from healthy litter mates was used for control. Picosirius stained specimens were compared objectively using an automated connective tissue analysis methodology that uses machine learning technology.
RESULTS:
Wound conditions for both wound-in-tumor and wound-alone models appeared grossly "healed" at POD14. On automated analysis, t-SNE assessment of wound-in-tumor specimens from the endogenous melanoma model showed clustering alongside uninjured tumor specimens suggesting that even with wounding, extent of scar formation within tumors is similar to baseline tumor desmoplasia. This can be compared with non-tumor wound healing, which showed distinct clustering of dermal scar specimens away from uninjured skin. On isolated analysis of the melanoma specimens, connective tissue from both wound-in-tumor and uninjured tumor conditions appeared highly similar. These results suggest that melanoma CAFs are unable to enact normal wound healing activities.
CONCLUSION:
In the context of dermal melanoma, fibroblasts do not recapitulate normal scar connective tissue deposition, suggesting terminal differentiation of these cells in the CAF context. PURPOSE: Sutures are essential medical devices for tissue approximation to achieve wound healing. Unfortunately, conventional sutures only serve as passive bystanders as they are limited to mechanical approximation, but not biological activation of cells to promote healing. When conventional sutures are applied to wounds with excessive mechanical loading, such as in cleft lip and palate repair, there is a high risk of wound dehiscence. To create improved suture devices, we developed SLI-F06 peptide coated sutures that introduce innovative bioactive properties. The SLI-F06 peptide actively promotes cell migration, cell contraction, and collagen crosslinking. We hypothesize that SLI-F06 coated sutures will accelerate wound tensile strength re-establishment to enhance wound healing.
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METHODS:
To test our hypothesis, SLI-F06 coated absorbable sutures were fabricated using a scalable, cost-efficient lyophilization process. The suture types (monofilament suture and braided suture) and fabrication procedures (simple lyophilization, polymer coating, and layer-by-layer coating) were compared and optimized based on in vitro characterizations, including scanning electron microscope (SEM), mechanical strength, loading capacity, and release kinetics. In vivo efficacy of the coated sutures was evaluated using primary wound closure on a Yorkshire pig model. 4.0-cm length × 0.5-cm width full thickness wounds (n=6) were prepared and approximated by sutures with or without SLI-F06 coating, respectively. The wound tissues were harvested 4 weeks post-surgery. The breaking strength of the closed wound was measured by Instron, the gross appearance of the wounds was determined by visual analogue scale assessment, and histological analysis was conducted to examine biocompatibility.
RESULTS:
Compared to the monofilament sutures, the braided sutures can be loaded with considerably more SLI-F06 peptide (0.039 vs. 0.1 mg/cm). Regardless of the coating method, SLI-F06 coating did not significantly alter the morphology and/or tensile strength of the sutures. The release kinetics of SLI-F06 from the sutures can be adjusted using different coating technologies, and in particular, the layerby-layer coating technology led to a unique biphasic (immediate and extended) release pattern. Importantly, in Yorkshire pig wounds, using SLI-F06 coated suture resulted in significantly increased wound breaking strength (1.55-fold), an improved gross appearance 4-weeks post-injury, and equivalent inflammatory infiltration as the uncoated suture.
CONCLUSIONS:
In summary, our results demonstrate that the innovative SLI-F06 coated sutures successfully promote wound healing by accelerating mechanical strength re-establishment and improving gross appearance, with no detectable adverse effects in this investigation. Unlike passive conventional sutures, these new bioactive SLI-F06 coated sutures significantly improved the wound healing process. Overall, this may decrease adverse clinical outcomes such as wound dehiscence in high risk patients with compromised healing or with high-tension wounds.
